ArticleBritish journal of cancer2023

Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer.

Josephine A Hinneh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.